SARTORELLO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.713
AS - Asia 331
EU - Europa 235
AF - Africa 9
SA - Sud America 4
OC - Oceania 1
Totale 2.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.710
SG - Singapore 142
CN - Cina 122
VN - Vietnam 51
IT - Italia 38
FI - Finlandia 37
SE - Svezia 37
GB - Regno Unito 30
DE - Germania 28
FR - Francia 18
NL - Olanda 12
UA - Ucraina 11
RU - Federazione Russa 9
CI - Costa d'Avorio 7
HK - Hong Kong 7
BE - Belgio 4
BR - Brasile 3
CA - Canada 3
ES - Italia 3
IE - Irlanda 3
IN - India 3
AT - Austria 2
JP - Giappone 2
RO - Romania 2
TR - Turchia 2
AR - Argentina 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PH - Filippine 1
UG - Uganda 1
Totale 2.293
Salva come PNG Salva come JPEG
Città #
Fairfield 307
Ashburn 156
Chandler 154
Houston 128
Cambridge 115
Woodbridge 114
Seattle 104
Ann Arbor 84
Wilmington 76
Singapore 71
Jacksonville 56
Dong Ket 50
Princeton 40
Santa Clara 37
Boardman 35
Beijing 26
San Diego 25
Nanjing 17
Medford 16
Helsinki 15
Washington 15
Padova 12
Roxbury 12
New York 8
Abidjan 7
Changsha 7
Hong Kong 7
Dallas 6
Des Moines 6
Hebei 6
Shenyang 6
Hefei 5
London 5
Borås 4
Los Angeles 4
Milan 4
Norwalk 4
Villafranca Padovana 4
Waanrode 4
Dublin 3
Florence 3
Kharkiv 3
Madrid 3
Redwood City 3
Tianjin 3
Tivoli 3
Frankfurt am Main 2
Guangzhou 2
Indiana 2
Istanbul 2
Pune 2
Shanghai 2
Auckland 1
Budapest 1
Campinas 1
Cormeilles-en-Parisis 1
Dalian 1
Dearborn 1
Delhi 1
Edinburgh 1
Garopaba 1
Guaíba 1
Jiangmen 1
Kampala 1
Kilburn 1
Lauterbourg 1
Linyi 1
Malo 1
Manila 1
Monte Grande 1
Ningbo 1
Nuremberg 1
Rockville 1
Shenzhen 1
Simi Valley 1
Southwark 1
Stockholm 1
Taiyuan 1
Tokyo 1
Tolbert 1
Toronto 1
Trento 1
Vienna 1
Vientiane 1
Totale 1.817
Salva come PNG Salva come JPEG
Nome #
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 132
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 128
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 116
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 111
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 107
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 103
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 103
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 102
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 95
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 91
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 89
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 87
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 85
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 83
Which assay is the most suitable to investigate von Willebrand factor functional activity? 83
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 81
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 81
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 81
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 80
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 77
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 74
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 71
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 68
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 53
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 47
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 46
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 40
Totale 2.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.874
article - articoli 9.650
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020114 0 0 0 0 0 0 0 0 48 28 21 17
2020/2021299 13 12 4 32 12 30 13 28 37 17 26 75
2021/2022364 16 29 70 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025362 1 50 42 36 91 26 30 33 53 0 0 0
Totale 2.314